These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33007139)

  • 1. An Advanced Apralog with Increased in vitro and in vivo Activity toward Gram-negative Pathogens and Reduced ex vivo Cochleotoxicity.
    Sonousi A; Quirke JCK; Waduge P; Janusic T; Gysin M; Haldimann K; Xu S; Hobbie SN; Sha SH; Schacht J; Chow CS; Vasella A; Böttger EC; Crich D
    ChemMedChem; 2021 Jan; 16(2):335-339. PubMed ID: 33007139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apralogs: Apramycin 5-
    Quirke JCK; Rajasekaran P; Sarpe VA; Sonousi A; Osinnii I; Gysin M; Haldimann K; Fang QJ; Shcherbakov D; Hobbie SN; Sha SH; Schacht J; Vasella A; Böttger EC; Crich D
    J Am Chem Soc; 2020 Jan; 142(1):530-544. PubMed ID: 31790244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin.
    Matt T; Ng CL; Lang K; Sha SH; Akbergenov R; Shcherbakov D; Meyer M; Duscha S; Xie J; Dubbaka SR; Perez-Fernandez D; Vasella A; Ramakrishnan V; Schacht J; Böttger EC
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10984-9. PubMed ID: 22699498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside antibiotics. XIV. Synthesis and activity of 6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-and 5-O-(beta-D-ribofuranosyl)apramycins.
    Abe Y; Nakagawa S; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1981 Nov; 34(11):1434-46. PubMed ID: 7319906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Design and Synthesis of Apramycin-Paromomycin Analogues: Importance of the Configuration at the 6'-Position and Differences between the 6'-Amino and Hydroxy Series.
    Mandhapati AR; Yang G; Kato T; Shcherbakov D; Hobbie SN; Vasella A; Böttger EC; Crich D
    J Am Chem Soc; 2017 Oct; 139(41):14611-14619. PubMed ID: 28892368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the 6'-hydroxy group and its configuration for apramycin activity.
    Mandhapati AR; Shcherbakov D; Duscha S; Vasella A; Böttger EC; Crich D
    ChemMedChem; 2014 Sep; 9(9):2074-83. PubMed ID: 25045149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens.
    Matsushita T; Sati GC; Kondasinghe N; Pirrone MG; Kato T; Waduge P; Kumar HS; Sanchon AC; Dobosz-Bartoszek M; Shcherbakov D; Juhas M; Hobbie SN; Schrepfer T; Chow CS; Polikanov YS; Schacht J; Vasella A; Böttger EC; Crich D
    J Am Chem Soc; 2019 Mar; 141(12):5051-5061. PubMed ID: 30793894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin.
    Bordeleau E; Stogios PJ; Evdokimova E; Koteva K; Savchenko A; Wright GD
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics.
    Sonousi A; Sarpe VA; Brilkova M; Schacht J; Vasella A; Böttger EC; Crich D
    ACS Infect Dis; 2018 Jul; 4(7):1114-1120. PubMed ID: 29708331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Antibacterial and Antiribosomal Activity of the 3
    Lubriks D; Haldimann K; Hobbie SN; Vasella A; Suna E; Crich D
    Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to apramycin in Escherichia coli isolated from animals: detection of a novel aminoglycoside-modifying enzyme.
    Hedges RW; Shannon KP
    J Gen Microbiol; 1984 Mar; 130(3):473-82. PubMed ID: 6374024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type cutoff for Apramycin against Escherichia coli.
    Yang Y; Xiao T; Li J; Cheng P; Li F; Yu H; Liu R; Muhammad I; Zhang X
    BMC Vet Res; 2020 Aug; 16(1):309. PubMed ID: 32847547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and characterization of aparmycin-resistant Escherichia coli from humans in Korea.
    Lim SK; Nam HM; Kim A; Jang GC; Lee HS; Jung SC
    Microb Drug Resist; 2011 Dec; 17(4):563-6. PubMed ID: 21905874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin.
    Davies J; O'Connor S
    Antimicrob Agents Chemother; 1978 Jul; 14(1):69-72. PubMed ID: 356726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    Juhas M; Widlake E; Teo J; Huseby DL; Tyrrell JM; Polikanov YS; Ercan O; Petersson A; Cao S; Aboklaish AF; Rominski A; Crich D; Böttger EC; Walsh TR; Hughes D; Hobbie SN
    J Antimicrob Chemother; 2019 Apr; 74(4):944-952. PubMed ID: 30629184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apramycin and gentamicin resistances in indicator and clinical Escherichia coli isolates from farm animals in Korea.
    Choi MJ; Lim SK; Nam HM; Kim AR; Jung SC; Kim MN
    Foodborne Pathog Dis; 2011 Jan; 8(1):119-23. PubMed ID: 21214385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tentative epidemiologic cut-off value and resistant characteristic detection of apramycin against Escherichia coli from chickens.
    Tian E; Muhammad I; Hu W; Wu Z; Li R; Lu X; Chen C; Li J
    FEMS Microbiol Lett; 2019 Aug; 366(16):. PubMed ID: 31518404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model.
    Kang AD; Smith KP; Berg AH; Truelson KA; Eliopoulos GM; McCoy C; Kirby JE
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene
    Plattner M; Gysin M; Haldimann K; Becker K; Hobbie SN
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAC(1): a new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycin.
    Lovering AM; White LO; Reeves DS
    J Antimicrob Chemother; 1987 Dec; 20(6):803-13. PubMed ID: 3326872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.